| Product Code: ETC7178752 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to rely on import shipments of large volume parenteral products, with key exporters including Australia, New Zealand, India, Bangladesh, and the USA. The market remained highly concentrated, with a high Herfindahl-Hirschman Index (HHI). Despite a strong compound annual growth rate (CAGR) of 6.89% from 2020 to 2024, the industry experienced a decline in growth rate from 2023 to 2024 at -15.21%. This data suggests potential shifts in market dynamics and highlights the importance of monitoring trends in the large volume parenteral sector for stakeholders in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Large Volume Parenteral Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Large Volume Parenteral Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Large Volume Parenteral Market - Industry Life Cycle |
3.4 Fiji Large Volume Parenteral Market - Porter's Five Forces |
3.5 Fiji Large Volume Parenteral Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Fiji Large Volume Parenteral Market Revenues & Volume Share, By Volume, 2021 & 2031F |
3.7 Fiji Large Volume Parenteral Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Fiji Large Volume Parenteral Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Fiji Large Volume Parenteral Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Fiji Large Volume Parenteral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring parenteral administration of medications |
4.2.2 Growing demand for efficient drug delivery systems in healthcare facilities |
4.2.3 Technological advancements leading to the development of innovative parenteral products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the production and distribution of large volume parenteral products |
4.3.2 High costs associated with the manufacturing and quality control of parenteral solutions |
4.3.3 Limited availability of skilled healthcare professionals for administering parenteral medications |
5 Fiji Large Volume Parenteral Market Trends |
6 Fiji Large Volume Parenteral Market, By Types |
6.1 Fiji Large Volume Parenteral Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Large Volume Parenteral Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Fiji Large Volume Parenteral Market Revenues & Volume, By Soft Bag LVP, 2021- 2031F |
6.1.4 Fiji Large Volume Parenteral Market Revenues & Volume, By Plastic Bottle LVP, 2021- 2031F |
6.1.5 Fiji Large Volume Parenteral Market Revenues & Volume, By Glass Bottle LVP, 2021- 2031F |
6.2 Fiji Large Volume Parenteral Market, By Volume |
6.2.1 Overview and Analysis |
6.2.2 Fiji Large Volume Parenteral Market Revenues & Volume, By 100 ml-250 ml, 2021- 2031F |
6.2.3 Fiji Large Volume Parenteral Market Revenues & Volume, By 250 ml-500 ml, 2021- 2031F |
6.2.4 Fiji Large Volume Parenteral Market Revenues & Volume, By 500 ml-1000 ml, 2021- 2031F |
6.2.5 Fiji Large Volume Parenteral Market Revenues & Volume, By 1000 ml-2000 ml, 2021- 2031F |
6.2.6 Fiji Large Volume Parenteral Market Revenues & Volume, By 2000 ml and more, 2021- 2031F |
6.3 Fiji Large Volume Parenteral Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Large Volume Parenteral Market Revenues & Volume, By Therapeutic Injections, 2021- 2031F |
6.3.3 Fiji Large Volume Parenteral Market Revenues & Volume, By Fluid Balance Injections, 2021- 2031F |
6.3.4 Fiji Large Volume Parenteral Market Revenues & Volume, By Nutritious Injections, 2021- 2031F |
6.4 Fiji Large Volume Parenteral Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Fiji Large Volume Parenteral Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Fiji Large Volume Parenteral Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.4 Fiji Large Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Fiji Large Volume Parenteral Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Fiji Large Volume Parenteral Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Fiji Large Volume Parenteral Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Fiji Large Volume Parenteral Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Fiji Large Volume Parenteral Market Import-Export Trade Statistics |
7.1 Fiji Large Volume Parenteral Market Export to Major Countries |
7.2 Fiji Large Volume Parenteral Market Imports from Major Countries |
8 Fiji Large Volume Parenteral Market Key Performance Indicators |
8.1 Rate of adoption of large volume parenteral products in healthcare facilities |
8.2 Number of new product launches and innovations in the parenteral market |
8.3 Patient satisfaction and outcomes related to the use of parenteral medications |
9 Fiji Large Volume Parenteral Market - Opportunity Assessment |
9.1 Fiji Large Volume Parenteral Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Fiji Large Volume Parenteral Market Opportunity Assessment, By Volume, 2021 & 2031F |
9.3 Fiji Large Volume Parenteral Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Fiji Large Volume Parenteral Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Fiji Large Volume Parenteral Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Fiji Large Volume Parenteral Market - Competitive Landscape |
10.1 Fiji Large Volume Parenteral Market Revenue Share, By Companies, 2024 |
10.2 Fiji Large Volume Parenteral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here